文献速递MDS 与骨髓增殖性肿瘤

CALR突变骨髓增殖性肿瘤巨核细胞中突变钙网蛋白与SOCE相互作用缺陷

Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms.
PubMed 文献 · Blood · 2020-01-01

约四分之一原发性血小板增多症或原发性骨髓纤维化患者携带CALR基因体细胞突变,以52-bp缺失(I型)和5-bp插入(II型)最常见。研究比较健康人与CALR突变MPN患者巨核细胞中钙网蛋白与钙库操纵性钙内流(SOCE)机制的相互作用,发现患者巨核细胞中突变钙网蛋白、ERp57与STIM1之间相互作用缺陷,激活SOCE并产生自发性胞质钙流,导致异常巨核细胞增殖,而特异性SOCE抑制剂可逆转该增殖。

要点

  • CALR突变MPN患者巨核细胞存在突变钙网蛋白、ERp57与STIM1相互作用缺陷。
  • 该缺陷激活SOCE并产生自发性胞质钙流,驱动异常巨核细胞增殖。
  • 特异性SOCE抑制剂可逆转患者巨核细胞的异常增殖。

核心结论

  • CALR突变MPN患者巨核细胞中SOCE调控钙流异常参与疾病病理生理。
  • SOCE可能成为抑制MPN中巨核细胞增殖及其临床后果的新治疗靶点。

研究设计与样本

  • 研究比较健康个体与CALR突变MPN患者巨核细胞中钙网蛋白与SOCE机制的相互作用。
  • 约四分之一原发性血小板增多症或原发性骨髓纤维化患者携带CALR体细胞突变。
  • CALR最常见突变为52-bp缺失(I型)和5-bp插入(II型)。

主要发现

  • 健康人巨核细胞中血小板生成素与c-Mpl结合诱导STAT5、AKT和ERK1/2激活,引起内质网IP3依赖性钙释放。
  • 健康人巨核细胞中钙释放导致ERp57介导的钙网蛋白与STIM1复合物解离,STIM1为SOCE机制蛋白,进而钙动员。
  • CALR突变MPN患者巨核细胞中突变钙网蛋白、ERp57与STIM1相互作用缺陷,激活SOCE并产生自发性胞质钙流。
  • 该异常导致巨核细胞异常增殖,使用特异性SOCE抑制剂可逆转。

关键数值与推荐

  • CALR I型突变为52-bp缺失,II型突变为5-bp插入。
  • 约四分之一原发性血小板增多症或原发性骨髓纤维化患者携带CALR体细胞突变。

临床怎么用

  • SOCE抑制剂可能逆转CALR突变MPN患者巨核细胞异常增殖。
  • SOCE可能作为CALR突变MPN的新治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Approximately one-fourth of patients with essential thrombocythemia or primary myelofibrosis carry a somatic mutation of the calreticulin gene (CALR), the gene encoding for calreticulin. A 52-bp deletion (type I mutation) and a 5-bp insertion (type II mutation) are the most frequent genetic lesions. The mechanism(s) by which a CALR mutation leads to a myeloproliferative phenotype has been clarified only in part. We studied the interaction between calreticulin and store-operated calcium (Ca2+) entry (SOCE) machinery in megakaryocytes (Mks) from healthy individuals and from patients with CALR-mutated myeloproliferative neoplasms (MPNs). In Mks from healthy subjects, binding of recombinant human thrombopoietin to c-Mpl induced the activation of signal transducer and activator of transcription 5, AKT, and extracellular signal-regulated kinase 1/2, determining inositol triphosphate-dependent Ca2+ release from the endoplasmic reticulum (ER). This resulted in the dissociation of the ER protein 57 (ERp57)-mediated complex between calreticulin and stromal interaction molecule 1 (STIM1), a protein of the SOCE machinery that leads to Ca2+ mobilization. In Mks from patients with CALR-mutated MPNs, defective interactions between mutant calreticulin, ERp57, and STIM1 activated SOCE and generated spontaneous cytosolic Ca2+ flows. In turn, this resulted in abnormal Mk proliferation that was reverted using a specific SOCE inhibitor. In summary, the abnormal SOCE regulation of Ca2+ flows in Mks contributes to the pathophysiology of CALR-mutated MPNs. In perspective, SOCE may represent a new therapeutic target to counteract Mk proliferation and its clinical consequences in MPNs.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Di Buduo CA, Abbonante V, Marty C, et al. Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms. Blood. 2020. PMID: 31697806. doi:10.1182/blood.2019001103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。